<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Summary of laboratory data</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Characteristic</th>
    <th>
     <italic>n</italic>
    </th>
    <th>OFI (
     <italic>N</italic> = 394)
    </th>
    <th>
     <italic>n</italic>
    </th>
    <th>All dengue patients (
     <italic>N</italic> = 1117)
    </th>
    <th>
     <italic>n</italic>
    </th>
    <th>Uncomplicated dengue (
     <italic>N</italic> = 836)
    </th>
    <th>
     <italic>n</italic>
    </th>
    <th>Intermediate dengue (
     <italic>N</italic> = 243)
    </th>
    <th>
     <italic>n</italic>
    </th>
    <th>Severe dengue (
     <italic>N</italic> = 38)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="11">At enrollment</td>
   </tr>
   <tr>
    <td> CRP (mg/L)</td>
    <td>394</td>
    <td>31.3 (10.2, 88.8)</td>
    <td>1117</td>
    <td>30.2 (12.4, 61.5)</td>
    <td>836</td>
    <td>28.6 (10.5, 58.9)</td>
    <td>243</td>
    <td>35.3 (17.9, 71.8)</td>
    <td>38</td>
    <td>26.2 (14.1, 71.1)</td>
   </tr>
   <tr>
    <td> Viremia level (× 10
     <sup>6</sup> copies/mL)
    </td>
    <td>–</td>
    <td>–</td>
    <td>1050</td>
    <td>35.5 (3.1, 269.6)</td>
    <td>783</td>
    <td>25.2 (2.0, 185.4)</td>
    <td>231</td>
    <td>92.9 (7.5, 690.5)</td>
    <td>36</td>
    <td>128.5 (33.1, 331.2)</td>
   </tr>
   <tr>
    <td> AST (UI/L)</td>
    <td>394</td>
    <td>30.0 (23.0, 40.0)</td>
    <td>1109</td>
    <td>43.0 (30.0, 67.0)</td>
    <td>831</td>
    <td>42.0 (30.0, 62.0)</td>
    <td>240</td>
    <td>52.0 (33.0, 92.2)</td>
    <td>38</td>
    <td>60.0 (43.0, 84.8)</td>
   </tr>
   <tr>
    <td> ALT (UI/L)</td>
    <td>394</td>
    <td>18.0 (13.0, 30.0)</td>
    <td>1113</td>
    <td>28.0 (18.0, 49.0)</td>
    <td>834</td>
    <td>27.0 (17.0, 46.0)</td>
    <td>241</td>
    <td>32.0 (21.0, 67.0)</td>
    <td>38</td>
    <td>29.0 (18.2, 41.2)</td>
   </tr>
   <tr>
    <td> Albumin (g/L)</td>
    <td>394</td>
    <td>45.5 (43.5, 47.5)</td>
    <td>1105</td>
    <td>45.0 (42.5, 47.1)</td>
    <td>828</td>
    <td>45.0 (42.7, 47.3)</td>
    <td>239</td>
    <td>44.3 (41.9, 46.9)</td>
    <td>38</td>
    <td>44.9 (42.6, 47.3)</td>
   </tr>
   <tr>
    <td> Creatine kinase (UI/L)</td>
    <td>394</td>
    <td>92.5 (70.2, 129.0)</td>
    <td>1012</td>
    <td>105.0 (77.8, 156.2)</td>
    <td>763</td>
    <td>104.0 (76.0, 149.0)</td>
    <td>221</td>
    <td>115.0 (83.0, 171.0)</td>
    <td>28</td>
    <td>138.0 (91.0, 270.0)</td>
   </tr>
   <tr>
    <td> WBC (× 10
     <sup>9</sup>/mL)
    </td>
    <td>394</td>
    <td>7.7 (5.5, 10.8)</td>
    <td>1113</td>
    <td>4.3 (3.2, 6.0)</td>
    <td>834</td>
    <td>4.3 (3.2, 6.0)</td>
    <td>241</td>
    <td>4.4 (3.1, 6.0)</td>
    <td>38</td>
    <td>4.0 (2.8, 4.9)</td>
   </tr>
   <tr>
    <td> Neutrophils (%)</td>
    <td>394</td>
    <td>71.0 (61.5, 79.0)</td>
    <td>1108</td>
    <td>67.5 (58.0, 75.2)</td>
    <td>830</td>
    <td>66.3 (57.0, 74.8)</td>
    <td>240</td>
    <td>70.0 (61.4, 78.0)</td>
    <td>38</td>
    <td>72.8 (60.3, 77.9)</td>
   </tr>
   <tr>
    <td> Lymphocytes (%)</td>
    <td>394</td>
    <td>16.5 (11.5, 24.1)</td>
    <td>1109</td>
    <td>18.6 (11.8, 26.9)</td>
    <td>831</td>
    <td>18.9 (12.4, 27.4)</td>
    <td>240</td>
    <td>16.9 (10.9, 24.4)</td>
    <td>38</td>
    <td>19.8 (11.8, 31.3)</td>
   </tr>
   <tr>
    <td colspan="11">Other time points</td>
   </tr>
   <tr>
    <td> Max HCT change* (%)</td>
    <td>360</td>
    <td>2.4 (− 1.5, 5.8)</td>
    <td>1112</td>
    <td>7.1 (2.4, 13.7)</td>
    <td>832</td>
    <td>5.4 (1.7, 9.9)</td>
    <td>243</td>
    <td>20.5 (8.6, 24.5)</td>
    <td>37</td>
    <td>16.7 (6.1, 28.2)</td>
   </tr>
   <tr>
    <td> Platelet nadir (× 10
     <sup>9</sup>/mL)
    </td>
    <td>383</td>
    <td>178 (143, 225)</td>
    <td>1113</td>
    <td>72.0 (40.0, 119.0)</td>
    <td>834</td>
    <td>89 (52, 127)</td>
    <td>242</td>
    <td>40.5 (22.0, 71.0)</td>
    <td>37</td>
    <td>18 (13, 30)</td>
   </tr>
   <tr>
    <td> CRP at follow-up (mg/L)</td>
    <td>30</td>
    <td>1.4 (0.5, 4.1)</td>
    <td>896</td>
    <td>0.8 (0.4, 2.0)</td>
    <td>668</td>
    <td>0.8 (0.3, 2.0)</td>
    <td>196</td>
    <td>0.8 (0.4, 2.0)</td>
    <td>32</td>
    <td>0.8 (0.5, 2.2)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Summary statistics are median (interquartile range)</p>
  <p>
   <italic>ALT</italic> alanine aminotransferase, 
   <italic>AST</italic> aspartate aminotransferase, 
   <italic>CRP</italic> C-reactive protein, 
   <italic>DOI</italic> day of illness, 
   <italic>HCT</italic> hematocrit, 
   <italic>OFI</italic> other febrile illnesses, 
   <italic>WBC</italic> white blood cell
  </p>
  <p>*Maximum HCT change was calculated by maximum HCT level at the acute phase (DOI 4 to 7) minus baseline HCT, then divided by baseline HCT. Baseline HCT was the minimum HCT level within DOI 1 to 3</p>
 </table-wrap-foot>
</table-wrap>
